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HaplotypeThe chemokine (C–C motif) receptors (CCR) 2 and 5 are members of a large family of G protein-coupled
receptors, playing important roles in asthma pathogenesis. Using standard sequencing techniques, a total of
15 single nucleotide and 8 insertion/deletion polymorphisms (DIPs) (5 novels) were identiﬁed in and around
these two genes. None of the studied polymorphisms (N=7, selected on the basis on linkage disequilibrium)
was associated with asthma in a case (N=315) – control (N=337) study and showed no evidence for non-
random transmission to individuals with asthma/atopy in Indian pedigrees (n=235). However, multilocus
haplotype analysis based on simulations yielded a P=0.00005 in the case–control study and a P=0.03 for
the family-based association studies. Furthermore, rs3918356 and rs743660 polymorphisms in CCR2 were
found to be associated with total serum IgE levels in both the study designs. Thus, our study supports a
signiﬁcant role for chemokine receptor polymorphisms in genetic susceptibility to asthma.Background
The chemokine (C–C motif) receptors; CCR2 (MIM#601267) and 5
(MIM#601373); are members of a large family of G protein-coupled
seven-transmembrane domain receptors, playing important roles in
asthma (NM#600807) pathogenesis [1,2]. CCR5 is expressed mainly
on the T helper (Th) cells producing type 1 cytokines such as
interferon-γ and tumor necrosis factor as well as on a major subset of
CD8+ cytotoxic T cells, [3] and binds the pro-inﬂammatory chemo-
kines CCL5 (regulated on activation, T-cell expressed and secreted),
CCL3, CCL4 and CCL2 [4], while CCR2 is expressed on monocytes,
basophils and eosinophils. The primary agonist of CCR2 is MCP-1
(CCL2), although other lesser agonists of this receptor include CCL8,
CCL7, CCL13, and CCL12 [1,5]. CCR5 plays a key role in the distribution
of CD45RO+ Tcells and contributes to the generation of a T helper (Th)
1 immune response. Since Th2 immune responses are critical for the
inﬂammatory reaction, it is hypothesized that the presence of CCR5
may delay the development of Th-2 mediated diseases like asthma.
Evidently, CCR5 knockout mice demonstrated a shift towards type2-
cytokine activation in a model of experimental colitis [6]. In contrary,
an impressive accumulation of CCR5-positive T cells and macrophages
is found in the lungs of the asthmatics after allergen challenge [2].
Also, the airways hyper responsiveness (AHR) was found to behosh@igib.res.in (B. Ghosh).
ll rights reserved.signiﬁcantly lower in A. fumigatus-sensitized CCR5−/− mice [7].
While, in a similar model, CCR2-deﬁcient animals exhibited an
increase in eosinophils and lymphocytes in the airways, serum IgE,
Th2 cytokines and Th2-induced chemokines, AHR, and ﬁbrosis in
comparison to wild type mice [8]. However, neutralization of CCR2
using speciﬁc anti-CCR2 mAb leads to the reduction of antigen-
induced bronchial HR and attenuates macrophage and eosinophil
accumulation in the BAL of a primate model of asthma [9]. Thus, the
role for both the chemokine receptors in asthma pathogenesis
remains controversial.
Few genetic epidemiology studies have also documented a role for
chemokine receptors and their ligands in the pathogenesis of asthma.
The presence of the 64I allele of rs1799864: ANG (V64I) in CCR2
conferred signiﬁcantly lower risk for the development of asthma in a
Korean population [10]. A 32-bp deletion in CCR5 (Δ32), which causes
loss of CCR5 cell surface receptors, has been associated with asthma
and atopy in some studies [11,12], but not in others [13,14]. Recently,
we have shown that the frequency of heterozygous mutant is much
higher in patient group, in comparison to the control group (P=
0.0089), thus shown a protective role for the deletion mutation [15].
However, because of its low frequency in our population, we were not
able to establish the role of CCR5 in atopic asthma. This observation, in
part, motivated further identiﬁcation of polymorphisms in the CCR5
gene and its ﬂanking regions including CCR2. Thus, we screened the
complete gene-length of the CCR5 and its ﬂanking regions, and also
sequenced the CCR2 exonic region and performed the association
162 J. Batra, B. Ghosh / Genomics 94 (2009) 161–168studies on the selected polymorphisms with asthma and serum total
IgE levels in case–control and family-based study designs.
Results
Resequencing of CCR2 and CCR5 gene and linkage disequilibrium
We sequenced all exons, introns and≈1.8 kb of 5′ ﬂanking region
of the human CCR5, and the exonic regions of CCR2 gene in 20
individuals irrespective of their disease status using the primers given
in Table 1. Besides 32 bp deletion, we have observed seven insertion/
deletion polymorphisms (DIPS) (ﬁve novel exonic variants) and 11
SNPs (1 novel) in CCR5 and four exonic variants in CCR2 in our
sequencing panel. A “CAA”DIP≈5 kb upstream of the translation start
site of CCR2 was also identiﬁed using Repeatmasker and conﬁrmed by
sequencing (Fig. 1A). None of the other reported mutations was found
to be polymorphic in our sequencing panel, thus pairwise LD among
the 17 polymorphisms (except for the rare polymorphisms) was
calculated. A pattern of strong linkage disequilibrium was observed
and three haplotype blocks were identiﬁed (Fig. 1B). Depending upon
their functional signiﬁcance and to capturemaximum alleles based on
LD, four polymorphisms from block 1, two from block 2 and one from
block 3 were chosen for further genotyping.
Association of CCR2 and 5 polymorphism with asthma and IgE
Allelic and genotypic frequencies for the ﬁve SNPs viz.
rs1799864: ANG, rs1799865: CNT (VAL64ILE), rs743660: GNA of
CCR2 and rs1799988: TNC and rs1800023: ANG of CCR5, and two
DIPs viz. a -/CAA (rs3918356) 5082 bp upstream of CCR2 and -/CAA
(rs41515644) in the 370 bp upstream of CCR5 translation start site
were determined in all the recruited individuals (Table 2). Genotype
frequencies of the polymorphisms in cases and controls are given in
Table 3. All the polymorphisms were found to be in Hardy–
Weinberg equilibrium in both groups, when analyzed separatelyTable 1
Primers and PCR conditions used for sequencing and genotyping the CCR2 and CCR5 polym
Primer name Segment /polymorphism Primer sequence
CCR5_1FP 1 5′-TCCTATGGGGTGTCCGAATGT-
CCR5_1RP 5′-GCAAACTAGAAGCTGAAAAGG
CCR5_2FP 2 5′-GTCTTGATCGCTGGGCTATTTC
CCR5_2RP 5′-TTTGTTCTCTGCTCATCCCACTA
CCR5_3FP 3 5′-TCATTTGCTTCTTGGATAGTAA
CCR5_3RP 5′-CCAAGTCCCAGAGAAGGTCATA
CCR5_4FP 4 5′-TATTTCTTGGGTATGTATGACA
CCR5_4RP 5′-GAGGCGGGCTGCGATTT-3′
CCR5_5FP 5 5′-TTCATGGAGGGCAACTAAAT-3
CCR5_5RP 5′-CCAGCCCAGGCTGTGTAT-3′
CCR5_6FP 6 5′-ACGCTTCTGCAAATGCTGTTCT
CCR5_6RP 5′-CTCCCTCCTTCCCATCCTTACGA
CCR5_7FP 7 5′-GGCATTGCTCCGTCTAAGTCAT
CCR5_7RP 5′-CCCCCACCCCCATTCAGTC-3′
CCR5_8FP 8 5′-AACCACAGGCAGCATTTAGCA
CCR5_8RP 5′-CTCACCGTTCATATTCAGAGGC
CCR2_1FP 9 5′-CTTTTCCCTGCCTTGCCACT-3′
CCR2_1RP 5′-TTTATAAACCAGCCGAGACTTC
CCR2_2FP 10 5′-CTTTTCCCTGCCTTGCCACT-3′
CCR2_2RP 5′-AGTTCTGCTCTGTCCCCACTTC
CCR5_SS1 rs1799988: TNC 5′-TGAGAAAAGCCCGTAAATAAA
CCR5_SS2 rs1800023: ANG 5′-GAAGAACTGTTCTCTGATT-3′
CCR2_SS1 rs1799864: ANG 5′-TTTTGCAGTTTATTAAGATGAG
CCR2_SS2 rs1799865: CNT 5′-AAGGTGTTCAGGAGAATGACA
CCR2_SS4 rs743660: GNA 5′-CCAGTGGGAACTCCTAAATCAA
CCR5_M1_FP rs3918356: (–)N(CAA) 5′-AGCCCGGGCAACATGACAAAA
CCR5_M1_RP 5′-CATTTGATTGTTGTTGGCTCTA
CCR2_M2_FP rs41515644: (–)N(CAA) 5′-GTGTGGTGGCGCCTGTAGTCC-
CCR2_M2_RP 5′-GAAAGCACCATCTCACCAAATA
Ref Seq: CCR5 (accession no. NM_000579); CCR2 (accession no. NM_000647).from distinct geographical areas and also from the combined meta-
analysis (data not shown). None of the seven polymorphisms
showed signiﬁcant association with atopic asthma (PN0.007) in any
cohort. In the families, also, none of the alleles demonstrated
signiﬁcant transmission distortion. Among the West-Indian families,
rs1800023 and rs41515644 polymorphisms demonstrated a weak
evidence of transmission disequilibrium (unadjusted P=0.01, using
recessive model). This distortion was not statistically signiﬁcant
(particularly after correction for multiple testing) and was not
observed North and North-east families (data not shown).
Total serum IgE levels were found to follow a log normal
distribution. When the cases and controls were compared with
respect to the log total serum IgE levels, a highly signiﬁcant difference
was obtained (t=7.4; df=5.71; Pb0.0001). Because increased serum
total IgE level is one of the major characteristics of atopic asthma, the
genetic effects of chemokine receptor gene polymorphisms were
tested on serum total IgE levels. None of the CCR5 variant was
associated with TsIgE levels (Table 4). On the other hand a signiﬁcant
effect was observed at the genotypic level for the rs3918356 and
rs743660 in the patients (P=0.0028 and 0.0002, respectively). The
mean log10 TsIgE levels in individuals with BB (with insertion) at
rs3918356 and with AA at rs743660 genotype were highest, followed
by individuals with rs3918356_AB/rs743660_GA and rs3918356_AA/
rs743660_AA genotypes (Table 4). Similar results were obtainedwhen
QTDT was used for family-based association test of genotypes with
log10 TsIgE (Table 4). The data was highly signiﬁcant (P=4×10−9 for
rs3918356 and P=2×10−10 for rs743660: GNA SNP) when analyzed
including dominance effect in the orthogonal model of Abecasis et al.
(Table 4) [16].
Haplotype association with asthma
The permutation test for signiﬁcant differences in haplotypes
frequency in case and control group using PHASE resulted in a P
value of 0.001 (data not shown) from the North cohort and 0.01 inorphisms.
Annealing temperature (°C) Size of PCR product (bp)
3′ 58 1278
TAA-3′
TA-3′ 58 1278
C-3′
TTT-3′ 58 1266
-3′
ACT-3′ 58 1269
′ 58 1208
AT-3′ 58 1070
-3′
-3′ 58 959
-3′ 58 630
-3′
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CT-3′
68 1168
TT-3′
C-3′ 55 23
50 20
GA-3′
AT-3′ 55 24
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GCAGTGG-3′
3′ 62 272
AAATCT-3′
Fig. 1. (A) Genomic structure of chemokine receptors CCR2, 5 and ﬂanking regions for the 24 polymorphisms (including Δ32) identiﬁed on the basis of NW_921651. The shaded boxes
represent the exons. The translation start site is indicated by+1. The SNPs genotyped in total study populations are represented in bold. The novel polymorphisms are represented by ⁎.
Numbers in () represents the corresponding rs IDs as given in panel B. Approximate positions of the sequencing primer pairs are shown in the lower half of the ﬁgure. (B) Haplotype-
block structure in and around CCR2 and CCR5 genes and general information regarding the SNPs from the sequencing cohort. The haplotype blocks were generated by Solid Spine of LD
of Haploview. Black boxes indicated strong evidence of linkage disequilibrium (LD) between the polymorphisms (r2=1), while white boxes showed no or little LD between pairs
(r2=0). 0br2b1 is represented by grey boxes. MAF, minor allele frequency. Obs, observed; Pred, predicted; HET, heterozygosity.
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of the frequencies in the two groups were assessed using Monte Carlo
test with one million simulations, highly signiﬁcant association was
observed with a normal χ2 (T1) 67.6, df=37; P=0.0016 and χ2
from 2×2 table clumped to produce maximum (T4) was 52.55,
P=0.000003 for the North population. This was also signiﬁcant
when all the samples from different geographical area were pooled to
construct and analyze the haplotypic association with asthma (T1-
χ2=64.8, df=40; P=0.008 and T4-χ2=42.68, P=0.00005). The
global test for the signiﬁcance in the families using HBAT also showed
a signiﬁcant difference in the observed and expected transmission
scores of the haplotypes (North families, P=0.049 at df=8; total
families, P=0.03 at df=10), when families with less ambiguity
about the parental haplotypes (maximum of 5) were utilized for the
analysis.Discussion
In this study, we examined the potential role of the regulatory and
functional CCR5 and CCR2 polymorphisms in the asthma patho-
genesis by an association study from a genetically untapped Indian
population. Recently, a number of polymorphisms in the regulatory,
promoter and exonic regions of the CCR5 and CCR2 genes that can
affect transcription and function have been identiﬁed and associated
with acceleration or protection with respect to HIV-1 progression to
AIDS, sarcoidosis and rheumatoid arthritis [17,18,19,20]. For example,
the homozygous allele combination 208G, 627C (rs1799988: TNC)
and 676A (rs1800023: ANG) in the CCR5 promoter region has been
linked to accelerated progression to AIDS in untreated individuals
[17]. No study so far has been undertaken to ﬁnd their association
with asthma and associated phenotypes except for a study showing
Table 2
Demographic proﬁle of the patient and the control groups in case–control study and the
probands in family studies.
Patients Controls Families
(N=315) (N=337) (Probands=235)
Native Place
North India 227 270 151
North-west India 64 48 59
North-east India 24 19 25
Mean age (years) 37.13 (±15.7) 34.3 (±13.5) 15.5 (±10.6)
Sex ratio (M Vs F) 50:50 58:42 60:40
Familial history of asthma/atopya All None All
Smoking historyb None None None
% Reversibility from baseline FEV1
(after β2-agonist usage)
N15% ND N15%
Log10-mean serum total IgE (IU/ml) 2.82 (±0.61) 2.41 (±0.71) 2.9 (±0.66)
Self reported history of allergies All None All
Patients and controls were recruited from Delhi, Lucknow (UP), Mumbai, and Guwahati
(Assam).
Parenthesis contains the values for standard deviation (SD). ‘ND’ denotes that the test is
not done.
a Control individuals were subjected to a questionnaire so as to eliminate all
individuals having atopic disorders or family history of atopic disorders. Only those
patients who have at least one ﬁrst-degree relative affected with atopy and/or asthma
were included for the study.
b Patients and controls known to have experienced smoking in the past three years,
or suffering from parasitic infections, were excluded from the study.
164 J. Batra, B. Ghosh / Genomics 94 (2009) 161–168non-association of two exonic variants of CCR5 with asthma [21] and
the other demonstrating the signiﬁcant association of 64I allele in
CCR2 with reduced risk of asthma [10].
Given the importance of chemokine receptors in allergic inﬂam-
mation, we determined the prevalence and association of the various
CCR2 and CCR5 polymorphisms with atopic asthma in Indian
population in samples recruited from different geographical regions.Table 3
Genotype distributions of CCR2 and CCR5 polymorphisms in patients and controls from diff
Polymorphism North West
(Genotype) Controls Cases Controls
(N=270) (N=227) (N=48)
rs3918356: (–)N(CAA)⁎⁎
AA 196 (73.41) 151 (68.33) 35 (72.92)
AB 61 (22.85) 64 (29.0) 12 (25.00)
BB 10 (3.75) 6 (2.71) 1 (2.08)
rs1799864: ANG
GG 204 (76.98) 175 (77.78) 40 (83.33)
GA 57 (21.51) 45 (20.0) 8 (16.67)
AA 4 (1.51) 5 (2.22) 0 (0.00)
rs1799865: CNT
CC 123 (46.42) 95 (42.22) 18 (37.50)
CT 120 (45.28) 103 (45.78) 29 (60.42)
TT 22 (8.3) 27 (12.0) 1 (2.08)
rs743660: GNA
AA 6 (2.31) 4 (1.79) 1 (2.17)
AG 48 (18.46) 54 (24.11) 8 (17.39)
GG 206 (79.23) 166 (74.11) 37 (83.33)
rs1799988: TNC
CC 48 (17.84) 35 (15.42) 5 (10.64)
CT 126 (46.84) 104 (45.81) 22 (46.81)
TT 95 (35.32) 88 (38.77) 20 (42.55)
rs1800023: ANG
GG 61 (22.68) 52 (22.91) 14 (29.17)
AG 133 (49.44) 104 (45.81) 21 (43.75)
AA 75 (27.88) 71 (31.28) 13 (27.08)
rs41515644: (–)N(CAA)⁎⁎
AA 40 (14.81) 37 (16.44) 11 (22.92)
AB 127 (47.04) 113 (50.22) 17 (35.42)
AB 103 (38.15) 75 (33.33) 20 (41.67)
⁎Armitage trend test P valueN0.05; parenthesis contains frequency of each genotype.
⁎⁎ AA = –/–: AB = –/CAA: BB = CAA/CAA.When we recruited our patients, there was no genetic map available
for the Indian sub-population, thus we decided to undertake a
separate analysis for cohorts recruited from different geographical
regions. However, later we observed that the individuals recruited in
our study, from West and North-east India were also of Indo-Aryan
origin except for few (which were excluded from the analysis). Thus
analysis of the pooled data from different geographical regions has
also been done to enhance the power of statistical analysis of our
study. Indeed, genetic homogeneity between the patients and controls
from pooled group was conﬁrmed by genotyping various loci, as yet
unlinked to asthma or related atopic disorders; the panel of unlinked
markers was D20S117, D6S1574, D20S196, D6S470, D12S368,
D16S404, D6S446, D16S3136, D6S441, D8S264, D8S258, D8S1771,
D8S285, D8S260, D8S270, D8S1784, D8S514, D8S284, D8S272,
D5S406, D5S416, D5S419, D5S426, D5S418, D5S407, D5S647, D5S424,
D5S641, D5S428, D5S2027, D5S471, D5S2115, D5S436, D5S422,
D5S408, D6S281, D6S308, D6S264, and D6S287. These markers were
analyzed for frequency distribution in cases and control using KS test
(PN0.05, data not shown). Additionally, we have validated our results
in family-based studies. Although, our case–control cohort and
familial cohorts are not completely independent (founders of the
families are included in our case–control studies), it is worth to
analyze them as two separate cohorts because; 1) the two study
designs are entirely different. 2) Age difference i.e. probands of the
familial cohort are younger than the cases/controls. Case–control
study design has a higher chance than a family-based study, of ﬁnding
a false-positive association. Since asthma is a complex disorder
believed to be caused by the interaction of many genes, each having
only a small effect, a case–control study, however, has provided us the
directions for further familial studies.
Initially, we aimed to study CCR5 and sequenced the complete
CCR5 gene and observed ﬁve novel polymorphisms in the 3′ UTR of
the gene. Four of them were present only in a single individual, whoerent geographical area of India.
North-east Total
Cases Controls Cases Controls Cases
(N=64) (N=19) (N=24) (N=337) (N=315)
50 (79.37) 11 (61.11) 16 (69.57) 242 (72.67) 216 (70.59)
12 (19.05) 7 (38.89) 5 (21.74) 80 (24.02) 81 (26.47)
1 (1.59) 0 (0.00) 2 (8.70) 11 (3.30) 9 (2.94)
49 (76.56) 12 (66.67) 15 (62.5) 256 (77.34) 239 (76.36)
15 (23.44) 5 (27.78) 8 (33.3) 70 (21.15) 68 (21.73)
0 (0.00) 1 (5.56) 1 (4.17) 5 (1.51) 6 (1.92)
31 (48.44) 9 (50.0) 13 (54.17) 150 (45.32) 139 (44.41)
27 (42.19) 6 (33.33) 9 (37.5) 155 (46.83) 139 (44.41)
6 (9.38) 3 (16.67) 2 (8.33) 26 (7.85) 35 (11.18)
0 (0.00) 1 (5.56) 1 (4.17) 8 (2.47) 5 (1.62)
10 (16.67) 8 (44.44) 9 (37.5) 64 (19.75) 73 (23.70)
50 (83.33) 9 (50.00) 14 (58.33) 252 (77.78) 230 (74.68)
8 (12.5) 4 (21.1) 4 (6.7) 57 (17.01) 47 (14.92)
36 (56.25) 6 (32.0) 11 (45.8) 154 (45.97) 151 (47.94)
20 (31.25) 9 (47.9) 9 (37.5) 124 (37.01) 117 (37.14)
10 (15.63) 9 (42.4) 8 (33.3) 84 (25.00) 70 (22.22)
40 (62.50) 7 (36.8) 11 (45.8) 161 (47.92) 155 (49.21)
14 (21.88) 3 (15.8) 5 (20.8) 91 (27.08) 90 (28.57)
6 (9.52) 7 (36.8) 4 (17.4) 58 (17.21) 47 (15.11)
36 (57.14) 7 (36.8) 14 (60.9) 151 (44.81) 163 (52.41)
21 (33.33) 5 (26.3) 5 (21.7) 163 (37.98) 101 (32.48)
Table 4
Log10 serum total IgE distribution in patients (case–control cohort) with respect to
different CCR2 and CCR5 genotypes, and the results of Quantitative Trait Disequilibrium
Test (QTDT) in asthmatic families of Indian origin.
Polymorphism
(Genotype)
Distribution of log10 TsIgE in
patients from case–control cohort
P values obtained from
QTDT analysis
No of
Individuals
log10 TsIgE SE P value Orthogonal Orthogonal
dominance
rs3918356:
(–)N(CAA)⁎⁎
AA 164 2.73 0.04 0.0028 0.0028 4.00E−10
AB 67 2.79 0.06
BB 6 3.46 0.21
rs1799864: ANG
GG 178 2.76 0.04 0.11 0.96 0.55
GA 56 2.74 0.07
AA 5 3.25 0.23
rs1799865: CNT
CC 104 2.69 0.05 0.007 0.088 0.03
CT 107 2.78 0.05
TT 28 3.03 0.10
rs743660: GNA
AA 3 3.97 0.29 0.0002 0.021 2.00E−10
AG 59 2.79 0.07
GG 177 2.74 0.04
rs1799988: TNC
CC 35 2.79 0.09 0.49 0.43 0.733
CT 117 2.73 0.05
TT 87 2.81 0.06
rs1800023: ANG
GG 55 2.79 0.07 0.21 0.52 0.23
AG 116 2.71 0.05
AA 68 2.85 0.06
rs41515644:
(–)N(CAA)⁎⁎
AA 37 2.83 0.09 0.14 0.4 0.6
AB 122 2.70 0.05
AB 77 2.84 0.06
ANOVA was used to analyze the association of log10 TsIgE with genotypes in asthmatic
patients of case–control cohort.
Ref Seq: CCR5 (accession no. NM_000579); CCR2 (accession no. NM_000647).
⁎⁎ AA=–/–: AB=–/CAA: BB=CAA/CAA. Data in bold represents the signiﬁcant
association with serum IgE levels.
Table 5
Results of the haplotype frequency estimation (above 1%) for the atopic asthma and
control populations obtained with PHASEv2.1 and “observed” and “expected”
transmissions in the family-based studies using HBAT.
S. no. Haplotypesa Case–control studiesb Family-based studiesc
Controls Patients Observed score Expected score
(N=337) (N=315) (N=236) (N=236)
1 1 C A G C C 1 2.37 1.11 0.032 16.2
2 1 C A G C C 2 3.86 2.06
3 1 C A G C T 2 18.55 19.37 0.166 59.3
4 1 C A G T C 1 21.36 23.65 0.236 77.4
5 1 C A G T C 2 4.01 2.22 0.027 12
6 1 C A G T T 1 1.19 1.27 0.02 3.6
7 1 C A G T T 2 1.19 0.95 0.023 11
8 1 C G G T C 2 3.86 3.02 0.039 17
9 1 C G G T T 1 1.78 0.16
10 1 C G G T T 2 12.31 15.56 0.127 49.9
11 1 T A G C T 2 8.75 11.11 0.099 41
12 1 T A G T T 2 1.04 0.16
13 2 C A G C T 2 2.67 2.38 0.019 13
14 2 C G A T C 1 9.2 11.9 0.074 31.3
15 2 C G A T C 2 1.19 0
The haplotype involves polymorphisms in an order rs3918356: (–)N(CAA), rs1799864:
ANG (VAL64ILE), rs1799865: CNT, 3 rs743660: GNA of CCR2, and rs1799988: TNC,
rs1800023: ANG, rs41515644: (–)N(CAA) of CCR5.
Ref Seq: CCR5 (accession no. NM_000579); CCR2 (accession no. NM_000647).
a Alleles: 1, wild type; 2, insertion.
b Chi-square from 2×2 table clumped to produce maximum (T4) was 42.68;
P=0.000051.
c Chi-squared test on 10 degrees of freedom=19.79; P=0.031 (maximum allowable
compatible mating haplotypes=5).
165J. Batra, B. Ghosh / Genomics 94 (2009) 161–168were non-asthmatic non-atopic controls. Thus, these mutationsmight
not play a role in atopic disorders, but could be a contributor in
protection against HIV susceptibility. The other novel mutation
(2872GNdel) was also present only in single patient in heterozygous
form. Thus, these mutations were not included in LD calculations.
Haplotype blocks were generated using Solid Spine of LD, an internally
developed method of Haploview, which searches for a “spine” of
strong LD running from one marker to another along the legs of the
triangle in the LD chart. On the basis of these blocks, seven
polymorphisms were genotyped in the two large cohorts of 662
individuals in case–control study and 822 in family-based studies. Our
single-marker tests for association using the Armitage trend test did
not yield signiﬁcant results for any of the seven analyzed poly-
morphisms. However, we found a signiﬁcant association of rs3918356
with total serum log10IgE levels. This particular DIP was present
≈20.4 kb upstream of the CCR5 and in the promoter-regulatory
region of CCR2. OVA-speciﬁc IgE has been shown to be signiﬁcantly
elevated in OVA-challenged CCR2−/− mutants [9]. Thus, it is possible
that this or any other SNP in LD may play a role in the regulation the
CCR2 transcription. Thus, we also decided to completely sequence the
exonic regions of CCR2 gene and found a signiﬁcant association of
rs743660: GNA SNP present in the 3′UTR of CCR2 gene to be associated
with serum total IgE levels. Given the condition, occurrence of homo-
zygotes for both SNP rs3918356 and rs743660 that were associated
with increased levels of log-transformed TsIgE is not frequent; only 6
subjects carry risk genotype for rs3918356 (2.5%) and 3 for rs743660
(1.2%), respectively. It would be important to revalidate our results in a
relatively larger samples or other independent populations. Never-theless, using mfold software we predicted very different secondary
structures between the normal and variant fragments, with the two
most stable predictions showing Gibbs free energy (ΔG)=−124.71
and −112.42 kcal/mol, respectively (Fig. 2). Thus we suspected that
the rs743660: GNA substitution may affect the secondary structure of
CCR2 mRNA and hypothesized a functional involvement of the A
variant allele in reducing CCR2 mRNA stability and thus its levels
[22,23]. This hypothesis is required to be further conﬁrmed by
reporter gene assays or correlation with the CCR2 expression levels.
Because haplotype analysis could be of higher informative value to
embody the contribution of a gene to a speciﬁc disease [24], we also
assessed the effects of haplotypes in our study population. Haplotypes
of each individual in case–control study were inferred using PHASE,
which uses a Bayesian approach incorporating a priori expectations of
haplotypic structure from population genetics and coalescent theory
to calculate the association statistics to compare the frequency in
cases and controls. Although we have not observed any speciﬁc
haplotype showing signiﬁcant frequency difference between cases
and control, we found signiﬁcant results for the overall analysis using
Monte Carlo simulations. An explanation for the fact that we obtained
signiﬁcant results only for the multilocus haplotype analyses could be
that the combination of the information of all SNPs increases the
sensitivity, and therefore the signiﬁcance, as also found in other
studies [25]. To further clarify the biological role of the two genes in
asthma pathogenesis, we constructed four loci and three loci
haplotypes for CCR2 and CCR5 respectively. There was no signiﬁcant
association for CCR2 haplotypes and asthma phenotypes, while for
CCR5, when haplotype frequencies in the two groups were compared
usingMonte Carlo test with onemillion simulations, highly signiﬁcant
association was observed with a normal χ2 (T1) 26.5, df=7;
P=0.00042 and χ2 from 2×2 table clumped to produce maximum
χ2 (T4) was 25.17, P=0.000019. Thus it is possible that CCR5 is
playing more important role in asthma pathology.
In the present study, we have recruited only those patients who
have at least one ﬁrst-degree relative affected with atopy and/or
asthma. As the case and control groups were age, sex, ethnically and
geographically matched, it is very unlikely that the haplotypic
Fig. 2. RNA secondary structure prediction. To predict the possible conformation of the wild type (A) and the rs743660: GNA variant fragments (B) of CCR2, we used the mfold web
server with default parameters and a folding temperature of 37 °C. The two most stable predictions obtained showed a ΔG of−124.71 and−112.42 kcal/mol, respectively. Arrows
indicate the region in which the rs743660: GNA SNP is located.
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from case–control data was proven by the transmission data from the
familial studies also. Therefore, it is unlikely that our results are due to
stratiﬁcation or an inherent statistical bias. Our ﬁnding is therefore in
accordance with our/others previous ﬁndings that CCR2/CCR5 may
have an immunoregulatory role in asthma.
In conclusion, the aimof our studywas to search for polymorphisms
in the CCR2 and 5 genes and to investigate their associationwith atopic
asthma. Altogether, based on haplotype analysis, we could show that
the analyzed polymorphisms are associated with the asthmatic
phenotype, while CCR2 polymorphisms have a genetic contribution
towards increased serum total IgE levels. Our study also indicates the
need for further studies on the 3q21 chromosomal region, as it is
possible that other candidate genes at this locus may be involved in the
susceptibility to asthma in Indian population. Our study also have
important implications in understanding the global distribution of
CCR2 and 5 polymorphisms and its possible impact on susceptibility
towards various immunological diseases including AIDS.
Methods
Subjects
In a multicentre based asthma-genetic-study program, families
ascertained through a total of 235 probands were recruited from
various collaborating hospitals of India and segregated according to
their geographical distribution (Table 2). Approval of the ethics
committees of all the participating centres and hospitals was
obtained. Written consents were obtained from all the participants
for genetic studies, performing skin prick test and drawing blood
samples. Study design was such that at least one atopic as well as
atopic asthmatic probands alongwith both the parents were collected.
Families were further extended wherever other members gave their
consent to participate. Thus a total of 822 individuals were recruited
with an average family size of 3.47 (3 to 8) individuals per family.
An independent cohort of 110 cases (from the above-mentioned
hospitals) and 140 controls (from the general population) was alsorecruited. Ameta-analysiswas performed including the disease status-
conﬁrmed founders of the above-mentioned families along with the
case–control cohort to increase the power of the study. Non-asthmatic
but atopic founders were however excluded from the meta-analysis.
Clinical evaluation of the phenotypes
Asthma, in the recruited study population was deﬁned by clinical
history and validated later by interview questions as described
previously [26]. Medical data on the diagnosis of asthma and atopic
diseases or other respiratory disorders, their duration, skin problems,
types and doses of medications, and history of tobacco smoking were
obtained by ﬁlling up detailed questionnaire. Details of environmental
factors, family history of asthma/atopy, and the geographical region of
origin and migration status were also enquired.
Patients and family members were diagnosed by physician for
asthma on the basis of National Asthma Education and Prevention
Program (Expert Panel Report-2) guidelines (http://www.nhlbi.nih.
gov/guidelines/asthma/asthgdln.pdf) and were examined for a self-
reported history of breathlessness and wheezing. All the probands
met the following criteria: a positive skin prick test, a positive
response to at least one of the two questions (Have you ever had
attacks of breathlessness at rest with wheezing? Have you ever had an
asthma attack?), associated with positive values for at least 2 out of
the following three parameters: presence of BHR (deﬁned as FEV1/
FVC below 80% at the time of attack and FEV1 improvement by
bronchodilator), hospitalization for asthma in life, or asthma therapy.
The clinical parameters are summarized in Table 2.
Fifteen common environmental allergens with both negative and
positive controls were used for the skin prick test [26]. Atopy was
deﬁned as a dichotomous variable, having wheal reaction equal to or
greater than histamine for at least on allergen. Serum samples from
both cohorts were analyzed for total IgE levels by using an enzyme
immunoassay based on the sandwich technique (Bethyl Laboratories
Inc., Montgomery, Texas, USA) except for few individuals (b5%) where
sera were not available. All IgE values were converted to the log-
natural scale for the analysis.
167J. Batra, B. Ghosh / Genomics 94 (2009) 161–168Healthy volunteers (referred to as normal controls) were recruited
from the general population (case matched geographical area) who
answered negatively to a screening questionnaire for respiratory
symptoms and on the basis of the criteria of having no symptoms or
history of allergic diseases. Individuals having a history of smoking
and parasitic/helminthic infestations were excluded from the study.
SPT and PFT were also performed, wherever consent was obtained.
Genomic DNA preparation
DNA was isolated from peripheral white blood cells using the
modiﬁed salting out method and was stored at −20 °C until further
analysis.
Sequence analysis
To screen for sequence variation in the complete CCR5 gene
(accession no. NM_000579),1.8-kb region of the CCR5 promoter region,
and CCR2 (accession no. NM_000647) coding region, we divided the
region into 10 segments and ampliﬁed each segment by PCR. PCR
products were then sequenced on an ABI 3100 capillary sequencer
(Applied Biosystems, Foster City, CA, USA) by Big Dye terminator kit V
3.1 using both forward and reverse primers (Table 1). Sequences were
aligned and analyzed using SeqManTm II. RNA secondary structures
were predicted by using the mfold web server (http://mfold.bioinfo.
rpi.edu/cgi-bin/rna-form1.cgi) setting default parameters and a folding
temperature of 37 °C using the last 500 bps of the CCR2mRNA.
SNP genotyping
The rs1799988: TNC and rs1800023: ANG polymorphisms in CCR5
were investigated in the study population using primers used to
amplify the 3rd segment and the primers up to penultimate base of
the SNP as detailed in Table 1 (CCR5_SS1 and CCR5_SS2 resp.).
Similarly, rs1799864: ANG (CCR2_SS1), rs1799865: CNT (CCR2_SS2)
and rs743660: GNA (CCR2_SS3) in CCR2 were genotyped using
primers for 9th and 10th segments. All the SNPs were studied using
SNaPshot ddNTP Primer Extension Kit (Applied Biosystems, Foster
City, USA). 1 U of calf intestinal phosphatase (CIP) (New England
Biolabs, Beverly, MA) was used to clean up the primer extension
reaction. These samples were subsequently electrophoresed using the
ABI Prism 3100 Genetic Analyzer as per the manufacturer's instruc-
tions. The results were analyzed using the program ABI Prism
GeneMapper v3.7 (Applied Biosystems, Foster City, USA).
Genotyping of repeat polymorphisms
Putative repetitive sequences in and around the two genes were
identiﬁed using the RepeatMasker™ software (http://ftp.genome.
washington.edu/RM/RepeatMasker.html). Two (CAA)n trinucleotide
repeats 20.4 kb (5 kb upstream of CCR2) and 370 bp upstream of the
+1 of the CCR5 were identiﬁed. Since, only two alleles were present
for both of them, they are referred as DIPs in the manuscript. These
DIPs were validated for distribution in our study population by means
of a PCR using a 6-FAM-labelled forward primer and a non-labeled
reverse primer (Table 1). Fragment lengths were determined using
the GeneMapper Software version 3.7 (Applied Biosystems, Foster
City, USA).
Statistical analysis
Linkage disequilibria between the polymorphisms identiﬁed by
sequencing the genomic DNA of 20 individuals were evaluated using
Haploview (http://www.broad.mit.edu/mpg/haploview/index.php)
[27]. An association analysis, based on the case–control design, was
performed for each polymorphism using the Armitage trend test,following the guidelines given by Sasieni as implemented in the
program FINETTI. The Armitage trend test based on the genotypes
remains valid even if HWE does not hold [28]. We tested whether the
genotype distribution was in HWE using FINETTI. For total serum IgE
levels, linear trends were tested in ANOVA models of log-transformed
values after making the distribution normal by excluding the extreme
outliers using Shapiro–Wilk test using JMP® (SAS Institute Inc., Cary,
N.C.). Haplotypes of each individual were inferred and analyzed using
the algorithm developed by Stephens et al. (PHASE v 2.1) [29].
Differences in haplotype frequencies were also compared in the two
groups using a Monte Carlo approach, by performing repeated
simulations (1 million in this case) as implemented in CLUMP v 2.2
[30]. CLUMP is a program designed to assess the signiﬁcance of the
departure of observed values in a contingency table from the expected
values conditional on the marginal totals. It works for any 2×N
contingency table, especially where N is large and the table is sparse.
The signiﬁcance is assessed using a Monte Carlo approach, by
performing repeated simulations to generate tables having the same
marginal totals as the one under consideration, and counting the
number of times that a chi-squared value associated with the real
table is achieved by the randomly simulated data. Family data was
analyzed for transmission of polymorphisms by the family-based
association test (FBAT) (http://biosun1.harvard.edu/~fbat) using an
additive and recessive genetic model to identify alleles with evidence
for associationwith asthma. FBATanalysis extends themethodology of
the transmission disequilibrium test to evaluate nuclear families
including both affected and unaffected offspring. It conditions on the
observed traits and parental genotypes, and where parental data are
missing, conditions on the offspring genotype conﬁguration to specify
the distribution of a score statistic. The conditional distribution is used
to calculate the mean and variance of each family's contribution to a
general score statistic. HBAT option was used for the haplotypic
association studies. Total serum log10 IgE levels were analyzed using
the Quantitative TDT (http://www.sph.umich.edu:80/csg/abecasis/
QTDT) [16]. The QTDT test statistics are obtained using likelihood-
ratio tests, on the basis of the assumption of a normal distribution for
the traits. An empirical P value based on the permutation of genotypes
is obtained to protect against possible deviations from either
normality or selection on the trait. We used orthogonal and
orthogonal dominance model, the orthogonal model is the general-
ization of the Fulker model, which allows for families of any size.
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